# Independent final interpretation review

**PASS. No blocking arithmetic, source-interpretation, denominator, or selection finding remains in the stable report.** This is a pass for faithful reporting and verified computation, not a pass of the scientific compatibility requirements.

The reviewed report is `analysis/audit_v1/REPORT.md`, SHA-256 `27303379d02340e367294ee058616e473803ab17ce563fc7db6c4762d979a49a`. Its output manifest is `82a6d2a23d0cdc43bf69c30c9d0a1c8223e79b7a2e00be11a6fd1139eb1451b1`. Exact code, authorization, release, source-freeze and report bindings are in `FINAL_REVIEW_BINDINGS.json`.

The root narrative, `docs/C3_SOURCE_CONSTRAINED_GENERATION_RESULTS_2026-10-31.md`, also passes review at SHA-256 `85930322e1492ad4999344466e3ad0bcac5a24997b6898a7452fe7d1f2b1747f`. Its rounded numbers match the aggregate report; its counts correctly distinguish sixteen unused-seed tables from twenty-four audited baseline/selected tables and 164 total executions. It correctly attributes scientific structure authorship to the Agent and parameter fitting to the scalar optimizer. The proposed future acceptance-rule comparison and multiple fitting draws are explicitly untested design questions, not demonstrated repairs or authorization to continue C3.

## Findings

- **Linear:** selected trial 26 reduces loss on the fitting seed and both unused seeds. Compatibility remains incomplete: the Pani age ≥70 mean exceeds the authored discrepancy limit on both unused seeds, and the age coefficient is just below its lower numerical bound on 19123. These are three seed/check failure events, involving two source quantities. The value 0.00799097657 versus 0.008 is a small literal threshold miss; it remains positive and is not a biological reversal or a clinically established difference.
- **Alternative:** selected trial 26 lowers fitting loss but increases loss on both unused seeds and fails the Pani age-slope requirement on both. Its unchanged baseline passes all twenty numerical criteria on both unused seeds. The report correctly preserves the fact that objective minimization lost a declared compatibility property; this does not authorize post-replay reselection of the baseline.
- **Structure comparison:** the selected alternative has lower aggregate loss and smaller worst Pani age-profile error, but introduces an age-slope failure relative to linear on 19111. It therefore fails the complete descriptive preference rule. Both structures remain retained; no winner is selected or advanced to a target.

The scientific Agent authored both structures, assumptions, parameters, bounds and criteria before execution. The subsequent parameter changes came from the scalar numerical optimizer. This unit does not demonstrate a new Agent scientific revision after feedback, a new target effect, clinical validity, or invention of calibration.

## Arithmetic and implementation review

The independent auditor's code uses ordinary mean, sample SD with ddof=1, event proportions, and raw-unit least-squares coefficients with the exact source selections and adjustment sets. Jansen's BMI and glucose projections remain separately adjusted for age/sex; Pani's age projection adjusts for sex/BMI/glucose. The fixed twenty-check weighted denominator is preserved. Missing checks cannot improve the objective by disappearing. The Pani mean loss scale of 0.05 remains distinct from its compatibility limit of 0.10 percentage points.

The reviewer found and reported one audit-code assertion error before the audit: changed scalar provenance was checked against the original text prefix rather than the actual numerical-calibration annotation. The analyst corrected it by reconstructing the exact expected annotation and added explicit trial-lineage verification. No frozen scientific file or numerical fit was changed.

The completed independent audit records 26,735 passing mechanics checks. This reviewer separately performed **647 aggregate metadata/arithmetic checks**: all 240 statistic records in twelve complete twenty-check groups, 120 paired error changes, literal criterion decisions, exact fixed denominators, source-panel identity, output-manifest hashes, code bindings and resource summaries. These counts are verification operations, not independent scientific replications. The reviewer did not independently reread fictional individual rows or rerun either analysis script.

Both sessions stopped at the minimum-step rule after 37 trials each; neither exhausted its forty-trial cap. All 74 trials were feasible and all 164 source-context executions succeeded. No scalar hit its bound. The report distinguishes actual elapsed/output/log observations from timeout-cap accounting and does not claim measured peak memory or monetary cost. Minimum-step stopping does not prove a global optimum or source incompatibility.

## Scope and closure

Unused seeds assess stability of the within-structure fit under the same evidence and assumed source populations. They are not new cohorts or independent biological confirmation. Engineering criteria do not become clinical tolerances or confidence intervals. Unknown covariance, source distribution/support assumptions, residual law, the unweighted Pani survey approximation, assay comparability, and transport remain unverified. The known source-specific anchors do not identify a new population's location.

The final report closes this bounded unit with both structures, all baseline/selected results and failures retained. No new fit, generation, parameter change, evidence search, target access or model training is warranted or performed by this review. All inspected results were C3 source aggregates; no historical target values informed the conclusions.
